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Summary: Cluster-randomized trials (CRTs) of infectious disease preventions often yield correlated, interval-censored
data: dependencies may exist between observations from the same cluster, and event occurrence may be assessed only
at intermittent clinic visits. This data structure must be accounted for when conducting interim monitoring and
futility assessment for CRTs. In this article, we propose a flexible framework for conditional power estimation when
outcomes are correlated and interval-censored. Under the assumption that the survival times follow a shared frailty
model, we first characterize the correspondence between the marginal and cluster-conditional survival functions, and
then use this relationship to semiparametrically estimate the cluster-specific survival distributions from the available
interim data. We incorporate assumptions about changes to the event process over the remainder of the trial—as well
as estimates of the dependency among observations in the same cluster—to extend these survival curves through the
end of the study. Based on these projected survival functions we generate correlated interval-censored observations,
and then calculate the conditional power as the proportion of times (across multiple full-data generation steps) that
the null hypothesis of no treatment e↵ect is rejected. We evaluate the performance of the proposed method through
extensive simulation studies, and illustrate its use on a large cluster-randomized HIV prevention trial.
Key words: Cluster-randomized trial; Conditional power; Interim monitoring; Interval censoring.
This paper has been submitted for consideration for publication in Biometrics
Conditional Power for Correlated, Interval-Censored Data 1
1. Introduction
Cluster-randomized trials (CRTs) are well suited for the study of infectious disease prevention
and intervention strategies (e.g., Pronyk, et al., 2006; Lemaitre et al., 2009). By collectively
randomizing groups of individuals to receive either the intervention or the standard-of-
care, CRTs lessen the possibility of treatment contamination across randomization arms and
allow investigators to capture both the direct and indirect e↵ects of the intervention (Hayes
and Moulton, 2017). However the data generated from these studies are often complexly
structured. The “clustering e↵ect” is a well-noted feature of CRTs: two individuals from
the same cluster are more likely to be similar to one another than two individuals from
di↵erent clusters. Furthermore, the outcome of interest in infectious disease CRTs is often a
time-to-event outcome, such as time to HIV seroconversion. In the event that this outcome
is asymptomatic or otherwise only observable via periodic examination (as is the case for
HIV seroconversion), it is also interval-censored. Thus the design, monitoring, and analysis
of these CRTs must account for correlated, interval-censored data.
Our focus here lies specifically on the issue of interim monitoring to permit early stopping
for e cacy or futility. Interim monitoring refers to the practice of evaluating a trial’s progress
while the trial is ongoing, and is typically conducted through a series of interim statistical
analyses (Proschan, et al., 2006). The results of these analyses guide study decisions re-
garding sample size re-estimation, resource allocation, and early termination, and thus have
important ethical and financial implications.
Two statistical frameworks are commonly used for determining if and when to stop a
clinical trial early: group sequential testing (Pocock, 1977; O’Brien and Fleming, 1979;
Pampallona and Tsiatis, 1994) and stochastic curtailment (Lan et al., 1982; Lachin, 2005).
Group sequential methods calculate the test statistic of interest at each interim look, and stop
the trial for either e cacy or futility if this test statistic crosses a pre-determined stopping
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boundary (Pampallona and Tsiatis, 1994). Stochastic curtailment approaches, on the other
hand, involve calculating the conditional power, the conditional probability of rejecting the
null hypothesis of no treatment e↵ect at the scheduled end of the trial, given both the
observed interim data and some conjecture about the remainder of the study. The trial stops
for futility if this conditional power is low (Lachin, 2005).
Standard conditional power formulae for exponential family outcomes typically rely on
the assumption that the test statistic, or some transformation thereof, is an asymptotically
Brownian motion with linear drift; under this assumption, the conditional power may be
expressed in a straightforward manner in terms of the standard normal cumulative distribu-
tion function (Lan et al., 1982; Lan and Wittes, 1988). This framework has since been
adopted for the interim monitoring of trials with more complexly-structured outcomes,
such as repeated measures or failure time data. In the repeated measures context, for
example, Wu and Lan (1992) discussed the conditions under which a test statistic based
on the linear mixed e↵ects model could give rise to a discrete Brownian motion. Lin et al.
(1999), on the other hand, addressed the monitoring of independent right-censored data,
using martingale theory to establish that a broad class of weighted log-rank type statistics,
possibly with covariate adjustment, converges to a Gaussian process. Martingale theory is
not, however, generally available for interval-censored data due to the di culty of defining
an appropriate filtration. While the history of the associated counting process is a natural
choice of filtration in the right-censored setting, this counting process is not well-defined for
interval-censored data: when no exact failure times are observed, the value of the counting
process at a particular time t, as well as the information generated by that process on the
interval [0, t], may be unknown. As such, the formulae used in Lin et al. (1999) cannot
be easily extended to interval-censored data, and it is otherwise not apparent that test
statistics suitable for analyzing correlated interval-censored data are asymptotically Gaussian
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processes. Simulation-based approaches for calculating conditional power with time-to-event
endpoints have also been proposed, but these methods are currently limited to independent,
right-censored data (Henderson et al., 1991).
Thus, while existing conditional power methods are able to address correlated data and
right-censored time-to-event data separately, extensions to data that are both correlated and
interval-censored are not available but are much needed. As a case in point, we consider the
Botswana Combination Prevention Project (BCPP), a cluster-randomized trial evaluating
the impact of combination HIV prevention on the 3-year cumulative incidence of HIV in 30
Botswanan communities (Gaolathe et al., 2016). To measure HIV incidence, a random sample
of HIV-negative members from each community was tested annually for HIV, resulting in
clustered, interval-censored data. When the study begin in 2013, one component of the
combination prevention package was immediate antiretroviral therapy initiation for all HIV-
positive individuals with high viral loads; the prevailing standard of care at the time was to
initiate treatment only for those individuals with CD4 counts below 350 cells/mm3. However,
during the course of the BCPP, the Botswana Ministry of Health updated the national
treatment guidelines for HIV to a universal-test-and-treat approach, recommending that
all infected individuals—regardless of CD4 count or viral load level—receive antiretroviral
therapy. This change likely reduced the magnitude of the expected intervention e↵ect and
raised concerns about the power of the study to detect the updated e↵ect. Interim monitoring
of the BCPP for futility was thus particularly salient, but di cult given current interim
monitoring and futility analysis methods (Gaolathe et al., 2016).
Motivated by this example, we propose a flexible simulation-based framework for esti-
mating conditional power with correlated, interval-censored data. Our approach models the
dependence between outcomes via a cluster-specific frailty and permits calculation of the
conditional power under any assumed baseline hazard function and hazard ratio over the
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remainder of the study. It may also be used with any final analysis method. The statistical
contributions of this paper are thus two-fold: it (i) presents the first conditional power method
to explicitly consider correlated interval-censored data and (ii) does so in a manner that
permits greater analytical flexibility than traditional formulae-based approaches.
The remainder of this paper is structured as follows. In Section 2, we describe in detail
our proposed conditional power method. Section 3 examines the performance of this method
across a range of data-generating mechanisms and clustering e↵ects, as well as its sensitivity
to misspecification of the dependence and to study design choices such as the number and
size of the randomized clusters and the width of the censoring interval. In Section 4 we apply
the proposed method to interim data patterned on the BCPP, and in Section 5 we conclude
with a brief summary and discussion.
2. Methods
Suppose that we conduct a cluster-randomized trial of M independent clusters (indexed by
i = 1, . . . ,M), with ni individuals (indexed by j = 1, . . . , ni) in cluster i. Each of these indi-
viduals is associated with a latent set ofK distinct monitoring times, {Yijk : k = 1, . . . , K}, at
which the outcome of interest would be assessed, as well as a set of R observation indicators,
{Rijk : k = 1, . . . , K}, withRijk = 1 if individual j in cluster i is present at the kth inspection.
The set of observed monitoring times is then given by {Y ⇤ijk = YijkRijk : k = 1, . . . , K}. Let
Tij be the time to event for individual j in cluster i, measured from study entry. Note that,
for asymptomatic events, we do not observe this failure time directly, but rather observe the
interval (Lij, Uij], where Lij is the last observed monitoring time at which individual j in
cluster i tests negative for the presence of the event, and Uij is the first observed monitoring
time at which individual j in cluster i tests positive. Individuals who remain event-free at
the last observed monitoring time are right-censored with observed interval (maxk{Y ⇤ijk},1).
We assume throughout that the observed monitoring times Y ⇤ij = {Y ⇤ijk : k = 1, . . . , K} are
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independent of the underlying time to infection, and that the underlying time to infection is
independent of the calendar time of study entry.
Suppose that an interim analysis is scheduled for calendar time TI , and that T
(i)
I is the
study time of the interim analysis, measured in time since randomization of cluster i. Our
proposed conditional power estimation procedure includes the following steps, as detailed in
Sections 2.1 to 2.4 below (Figure 1). We (1) estimate the conditional survival function in
each of the trial communities through time T (i)I and then (2) use these estimated curves—
as well as assumptions regarding the subsequent event process and underlying dependence
structure—to extend the survival functions through the remainder of follow-up. We then
(3) use a truncated inverse probability integral transform method to generate complete-trial
observations from these extended curves and (4) perform the prespecified final analysis on
this complete-trial dataset. Finally, we (5) estimate the conditional power of the trial by
repeating this data generation and analysis procedure multiple times, and by calculating the
proportion of times that the null hypothesis of no intervention e↵ect is rejected.
[Figure 1 about here.]
2.1 Estimation of the Interim Survival Functions and Dependence Structure
Let Xi indicate cluster-level randomization to either intervention (Xi = 1) or standard-of-
care (Xi = 0) at baseline. We assume that individual outcomes are independent conditional
on cluster membership, and that the hazard in cluster i can be written as
 (t|Xi; ⌘i) =  (t|Xi = 0) exp( Xi + ⌘i), (1)
where exp(⌘i) is a cluster-specific frailty and  (t|Xi = 0) is the baseline hazard function
when ⌘i
set
= 0. We also assume that the frailties follow a lognormal distribution, exp(⌘i) ⇠
LogNormal(0,  2), as the lognormal model has an appealing computational connection to
generalized linear mixed models with random intercepts (Ripatti and Palmgren, 2000) and
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admits an intuitive relationship between  2 and the coe cient of variation, k:
k =
q
V ar
 
 (t|Xi; ⌘i)|Xi
 
E
 
 (t|Xi; ⌘i)|Xi
  =pe 2   1.
Our approach may, however, be easily generalized to other common frailty distributions (Web
Appendix A). Throughout we will adopt the convention that  (t|Xi; ⌘i) and S(t|Xi; ⌘i) denote
the conditional hazard and survival functions within cluster i; that  (t|Xi) and S(t|Xi)
denote the hazard and survival functions marginalized over cluster membership; and that
 (t|Xi) and S(t|Xi) denote the conditional hazard and survival functions when ⌘i set= 0.
Under the shared frailty model in (1), the conditional survival function in cluster i is
equivalently given by S(t|Xi; ⌘i) = S(t|Xi)exp(⌘i). Provided that we are able to estimate both
S(t|Xi) and exp(⌘i), we may then take bS(t|Xi; ⌘i) = bS(t|Xi)exp(b⌘i) for t in [0, T (i)I ]. Estimating
the conditional survival functions in this fashion presents several notable advantages over
stratified estimation of S(t|Xi; ⌘i) within each cluster: it (i) permits explicit characterization
of the underlying dependence structure while (ii) e↵ectively leveraging information from all
M clusters. This latter point is of particular importance when the outcome of interest is
rare and the amount of information available in cluster i is otherwise small. Thus estimation
of S(t|Xi; ⌘i) under model (1) reduces to estimation of the common conditional survival
function when ⌘i = 0, S(t|Xi), as well as the M cluster-specific frailty terms, exp(⌘i).
Methods for the semiparametric estimation of S(t|Xi) according to (1) are, however,
generally limited, while methods for the nonparametric estimation of the marginal survival
function, S(t|Xi), are readily available in standard statistical software (e.g., Turnbull, 1976;
Wellner and Zhan, 1997). The relationship between these two curves depends on the as-
sumed frailty distribution (see Web Appendix B for further discussion), but may—under the
lognormal frailty model—be approximated by
S(t|Xi) ⇡ S(t|Xi)

1 +
 2
2
logS(t|Xi) {logS(t|Xi) + 1}
 
. (2)
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See Appendix A for the derivation of (2). A semiparametric estimator of S(t|Xi) is then given
by the root of g(x) = x{1 +  22 log x(log x+ 1)}  S(t|Xi), which in turn requires reasonable
estimates of S(t|Xi) and  2.
To that end, we nonparametrically estimate the marginal survival function in each inter-
vention arm according to an independence data likelihood:
MY
i=1
niY
j=1
 
S(Lij|Xi)  S(Uij|Xi)
 
.
Although the independence likelihood is a misspecified version of the joint distribution—thus
precluding valid inference on, for example, second-order terms—it still permits consistent
estimation of the marginal parameters S(t|Xi = 0) and S(t|Xi = 1) (Chandler and Bate,
2007). Under nonparametric estimation, these survival functions are identifiable only up
to the equivalence class of right-continuous, non-increasing functions defined by the values
of {S(Lij) : i = 1, . . . ,M ; j = 1, . . . , ni} [ {S(Uij) : i = 1, . . . ,M ; j = 1, . . . , ni}. While
convention typically takes the nonparametric maximum likelihood estimator (NPMLE) to
be the step function within this equivalence class, we instead use linear interpolation to
identify the marginal survival functions wherever the NPMLE is non-unique. This choice is
made in recognition of the fact that—in settings where the censoring intervals are wide—the
NPMLE may be unidentified on large regions of the support of Tij; it may not be reasonable
to assume that the survival function is flat during these inter-monitoring periods.
Recovering S(t|Xi) from S(t|Xi) also requires estimates of the variance term  2, while final
estimation of S(t|Xi; ⌘i) requires estimates of the frailty terms ⌘ = {⌘i : i = 1, . . . ,M}. Due
to a lack of reliable software for frailty estimation with correlated interval-censored data,
we first transform the interval-censored observations into right-censored data via mid-point
imputation (Law and Brookmeyer, 1992) and then fit model (1) using a penalized partial
likelihood approach (Therneau et al., 2003). This allows us to iteratively estimate both b 2
and b⌘ = {b⌘i : i = 1, . . . ,M}. As an aside, we note that—while mid-point imputation has
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been shown to produce biased coe cient estimates in Cox models fit to independent data—
the simulation studies in Section 4 suggest that any bias in the estimation of  2 and ⌘ has
limited impact on the final conditional power estimates (Law and Brookmeyer, 1992).
Given b 2 and b⌘, we take bS(t|Xi) to be the root of g(x) = x{1+ b 22 log x(log x+1)} bS(t|Xi),
and may then estimate bS(t|Xi; ⌘i) = bS(t|Xi)exp(b⌘i).
2.2 Specification of the Event Process over the Remainder of the Trail
In order to calculate the conditional power, we also require some set of assumptions about
the shape of the two conditional hazard functions when ⌘i
set
= 0,  (t|Xi = 0) and  (t|Xi = 1),
over the remainder of the trial. Denote these hypothesized future values by e (t|Xi). Then
under the assumption that there are no temporal trends in the event process of interest—so
that the survival function S(t|Xi) is the same for all clusters with intervention assignment
Xi, regardless of the time of study entry—the complete-trial survival function for the ith
cluster, eS(t|Xi; b⌘i) is given by8>>><>>>:
bS(t|Xi)exp(b⌘i), t 6 T (i)I
bS(T (i)I |Xi)exp(b⌘i) expn  R tT (i)I e (u|Xi)exp(b⌘i)duo , t > T (i)I .
(3)
The shape of these projected conditional hazard functions may be informed by scientific
knowledge or determined by the investigator: our method permits any reasonable specifica-
tion of e (t|Xi = 0) and e (t|Xi = 1). The projections may also be informed by the available
interim data, and we detail one such approach to specifying e (t|Xi) below.
Within each trial arm, we approximate the conditional hazard function prior to interim via
a step function with prespecified and equally-spaced knot points {⇠t : t = 0, . . . , n}, where
⇠0 = 0 and ⇠n = TI . Let  Xi(t) be the piecewise component on the interval [⇠t 1, ⇠t) in the
arm with intervention assignment Xi, so that
S(⇠t|Xi) = exp{  Xi(t)(⇠t   ⇠t 1)}S(⇠t 1|Xi)
Conditional Power for Correlated, Interval-Censored Data 9
and
 Xi(t) = (⇠t   ⇠t 1) 1
 
logS(⇠t 1|Xi)  logS(⇠t|Xi)
 
.
We then estimate b Xi(t) by replacing S(⇠t 1|Xi) and S(⇠t|Xi) with the estimated values of
the conditional survival functions when ⌘i = 0.
Let   0 and   1 be projected multiplicative changes to the conditional hazard function in
the standard-of-care arm and in the intervention arm, respectively, over the remainder of the
trial. We introduce these parameters to accommodate clinical settings in which the future
event process is expected to di↵er systematically from that observed at interim, perhaps in
light of delays in intervention roll-out or mid-trial modifications to the intervention. In the
absence of additional information regarding the form of e (t|Xi), we make the final simplifying
assumption that both e (t|Xi = 0) and e (t|Xi = 1) are constant, and then set e (t|Xi = 0) =
 0 ·  0 and e (t|Xi = 1) =  1 ·  1 , where  Xi = n 1Pnt=1 b Xi(t).
2.3 Simulation of the End-of-Trial Data
In order to generate a final complete-trial dataset that captures both the observed interim
data and the projected future event process, we must first identify the subset of study
participants who are still at risk for the event of interest at interim. To that end, we note
that, at the time of the interim analysis, there are three possible outcomes for individual j in
cluster i: either (i) they have been observed to have the event of interest; (ii) they have not
had the event of interest but remain under active follow-up; or (iii) they have been lost to
follow-up prior to time TI . Note that if missingness at the monitoring times is assumed to be
intermittent rather than monotone, there may be no trial participants with interim outcome
(iii). All individuals with interim outcomes (i) and (iii) thus have complete data at the time of
the interim analysis; those with interim outcome (ii) remain at risk for the event of interest.
For this last subset of individuals, we then simulate completed observations by generating
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both an underlying time to event and the subsequent observation process. The final complete-
trial dataset then consists of the observed records from individuals with interim outcomes
(i) and (iii) and the simulated records from individuals with interim outcome (ii).
2.3.1 Simulation of the underlying time to event. Each individual j in cluster i with
interim outcome (ii) is e↵ectively right-censored at the time of the interim analysis, in that
their observed censoring interval is (Lij,1). Thus we wish to generate simulated times to
event eTij according to the complete-trial survival function for cluster i given in (3) and subject
to the restriction that eTij > Lij. In this way, the simulated eTij will be consistent with both the
observed interim data and the projected event process over the remainder of the trial. To do
so, we first define the generalized inverse function eS 1i (!|Xi; b⌘i) = inf{t|eSi(t|Xi; b⌘i) 6 !} and
let U ⇠ Uniform 0, eSi(Lij|Xi; b⌘i) . Then eTij := eS 1i (U |Xi; b⌘i) follows the desired truncated
distribution, with eTij > Lij. Appendix B provides formal justification for this truncated
inverse probability integral transform method.
2.3.2 Simulation of the missingness and interval-censoring mechanisms. We also require
some method for simulating the subsequent observation process, which in turn requires gen-
eration of both the latent monitoring times, eYijk, and the observation indicators, eRijk. While
we outline some possible modeling choices below, we note that any reasonable specification
of the monitoring and missingness processes reflecting the trial experiences is permitted.
In CRTs and other clinical setting, monitoring times are typically planned a priori, though
the actual visit dates of the individual study participants will inevitably vary in practice.
Suppose that, at the time of the interim analysis, an additional 0 < K 0ij < K visits
are planned for the remainder of the study, and that these visits are scheduled for study
times ⌧K K0ij+1, . . . , ⌧K . To incorporate uncertainty around the scheduling of these visits, we
simulate the remaining monitoring times eYijk ⇠ Uniform(⌧k   , ⌧k+  ) for some prespecified
  > 0 and for k = K  K 0ij + 1, . . . , K. We also set eYij,K+1 :=1.
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Missingness at these monitoring times may be modeled as either intermittent or monotone.
In the case of the former, the observation indicators {Rijk : k = K  K 0ij + 1, . . . , K} are a
sequence of Bernoulli random variables, where the probability of being observed at time k,
⇡Rijk, optionally depends on the available baseline covariates and the prior history of miss-
ingness. ⇡Rijk may then be estimated using a generalized linear mixed model with individual-
and cluster-specific frailties and a logit link. We then simulate eRijk ⇠ Bernoulli(b⇡Rijk).
Alternatively, under monotone missingness, the observation indicators for individual j in
cluster i represent a coarsening of some latent loss to follow-up time, Cij, in that Rijk =
I(Yijk 6 Cij). Simulation of the observation indicators {Rijk : k = K   K 0ij + 1, . . . , K}
thus reduces to the simulation and appropriate transformation of this time. To that end, we
first assume that Cij ⇠ Exp( C), where  C is the rate of study attrition. To estimate  C
from the observed data, we additionally note that the Cij are, in e↵ect, interval-censored. To
see this, consider again the three possible outcomes for individual j in cluster i at interim.
Under interim outcome (i), the censoring interval for Cij is simply [Uij,1), while under
interim outcome (ii) the censoring interval is [Lij,1). Under interim outcome (iii), let
YijK00ij be the time of the last observed visit and ⌧ij,K00ij+1 be the (planned) time of the first
missed visit. Then the corresponding censoring interval is [YijK00ij , ⌧ij,K00ij+1). Regardless of the
outcome scenario, we denote the observed interval for Cij as [L⇤ij, U
⇤
ij), and estimate  C by
maximizing the independence likelihood. We may then use the truncated inverse probability
integral transform to simulate eCij ⇠ Exp(b C) subject to eCij > L⇤ij. The set of corresponding
observation indicators is simply { eRijk = I(eYijk 6 eCij) : k = K  K 0ij + 1, . . . , K}.
Regardless of the assumed missingness mechanism, we set the observation indicator for
the final visit time eYij,K+1 to be eRij,K+1 := 1. Then the simulated observation process post
interim analysis is given by {eY ⇤ijk = eYijk eRijk : k = K  K 0ij + 1, . . . , K + 1}.
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2.3.3 Generation of the final complete-trial observations. For each study participant with
interim outcome (ii), we first simulate both the underlying time-to-event, eTij, and the
subsequent observation process, {eY ⇤ijk : k = K  K 0ij + 1, . . . , K + 1}. Let eY ⇤ij represent the
corresponding full-trial observation process, comprised of both the observed and simulated
inspections: eY ⇤ij = {Y ⇤ijk : k = 1, . . . , K K 0ij}[{eY ⇤ijk : k = K K 0ij+1, . . . , K+1}. Then the
final simulated observation is (eLij, eUij], where eLij = max{eY ⇤ijk : eY ⇤ijk 2 eY ⇤ij and eY ⇤ijk < eTij}
and eUij = min{eY ⇤ijk : eY ⇤ijk 2 eY ⇤ij and eY ⇤ijk > eTij}. A diagram further illustrating the process
of generating complete-trial observations is provided in Figure 2.
[Figure 2 about here.]
2.4 Calculation of the Conditional Power
For a given specification of e (t|Xi) and of the monitoring and missingness processes, we
generate C complete-trial datasets with correlated interval-censored outcomes, and then
conduct the prespecified final analysis on each of these simulated datasets; potential analysis
methods for correlated interval-censored data include mixed-e↵ects accelerated failure time
modeling (e.g., Koma´rek and Lesa↵re, 2007) and randomization-based inference (Wang and
De Gruttola, 2017). We then calculate the conditional power as the proportion of the C
p-values that are significant at the desired ↵ level.
2.5 Sensitivity Analyses
In order to better guide study termination decisions, we recommend that investigators
conduct a series of sensitivity analyses for the conditional power. These sensitivity analyses
might take the following form. To account for the presence of estimation or investigator
uncertainty, the analyst might first construct confidence intervals for each estimated interim
parameter (e.g., the conditional hazard functions) or plausible intervals for each projected
component of the event process, and then recalculate the conditional power at various values
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across this plausible region. This produces a range of conditional power values consistent
with the observed data and/or the investigator’s uncertainty about the remainder of the
trial. Other potential sensitivity analyses include calculating the conditional power under the
null trend or under the minimum clinically-meaningful e↵ect. Finally, in order to evaluate
the impact of clustering on the final probability of study success, investigators may also wish
to calculate the conditional power under an array of plausible coe cients of variation and
associated frailty terms.
3. Simulation Study
We conducted a series of simulation studies to examine the performance of our proposed
conditional power method, as well as to characterize its robustness to the number and size of
clusters, the width of the censoring interval, and the specification of the frailty distribution.
3.1 Simulation Settings and Evaluation Procedure
3.1.1 Data generating mechanism. We first generated completed CRTs of M = 30 pair-
matched clusters and ni ⇠ Uniform(250, 350) individuals in each cluster, with one member of
each cluster pair randomized to the intervention. The true time to event for each participant
was generated according to model (1) with  (t|Xi = 0) :=  0 and ⌘i ⇠ N(0,  2), and was
subject to monitoring at study times Yijk ⇠ Uniform(⌧k   4, ⌧k + 4) for k = 1, . . . , 4 and ⌧k
the kth element of {52, 104, 156, 208} weeks. Participant drop out was separately modeled
as monotone with Cij ⇠ Exp(0.002), corresponding to an overall loss to follow-up rate of
approximately 10% per year. We interval-censored each time to event as a function of the
simulated observation process, and then created the interim analysis datasets by truncating
the observations after the completion of all ⌧2 monitoring visits.
3.1.2 Simulation settings and structure. We considered two possible values for the con-
ditional baseline hazard,  0 = 0.001 and 0.01, and varied the conditional intervention e↵ect
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  from [ 1, 1] at 0.1 intervals. We also considered  2 = 0, 0.06, and 0.22, corresponding
to approximate coe cients of variation of k = 0, 0.25, and 0.5, respectively. Our primary
simulation study consisted of 1000 simulation replicates for each combination of the baseline
hazard, intervention e↵ect, and log-frailty variance. We also conducted a series of more
focused simulations in which we varied the number and size of the clusters, the width of the
censoring interval, and the frailty distribution. We took   0 =   1 = 1 throughout.
3.1.3 Analysis method. For each generated interim dataset, we evaluated the conditional
power by testing the null hypothesis of no intervention e↵ect across 500 sets of projected
complete-trial data using a permutation test (Wang and De Gruttola, 2017). Our test statistic
was the sum of the within-pair di↵erences in cumulative incidence, T obs =
P15
g=1
 b⇤1g  b⇤0g ,
where g indexes cluster pairs and b⇤Xig is the estimated cumulative incidence in the cluster
from pair g with intervention assignment Xi. We constructed the permutation null distri-
bution by randomizing treatment assignment within each matched pair, and then sampled
P = 1000 permutation test statistics T ⇤p in order to approximate the corresponding p-value
for T obs:
1+
PP
p=1 I(|T ⇤p |>|T obs|)
P+1 . The conditional power was taken to be the proportion of these
500 p-values that reached significance at an ↵ = 0.05 level.
3.1.4 Performance evaluation. To evaluate the overall performance of our conditional
power method, we compared the mean conditional power across the 1000 simulation repli-
cates to the simulated power for that setting. While we note that the conditional and
unconditional power of a trial are not directly comparable, the mean of the empirical
conditional power distribution estimates the trial power. In particular, if µs is the empirical
probability measure for the observed interim data, I, across the s = 1000 simulation
replicates and µ is the true probability measure for I, thenZ
P
 
p(D) 6 ↵  I  dµs ⇡ Z P  p(D) 6 ↵  I  dµ = P (p(D) 6 ↵)
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for any p-value p(D) derived from the complete-trial data, D. Thus, if our conditional power
method performs as designed, we would expect the mean conditional power to approximate
the simulated power for each simulation setting. We also calculated the conditional power
under the modification (unachievable in practice) in which e (t|Xi = 0) := e 0, e (t|Xi = 1) :=e 1,  2, and ⌘ were all set to their data-generating values. This allowed us to isolate whether
any discrepancies between the mean conditional power and the simulated power were the
result of the projection procedure, the specification and estimation of the parameter vector,
or both.
To examine our ability to recapitulate key features of the original complete-trial datasets,
we also recorded for each simulation replicate: the mean projected number of events in each
trial arm; the mean projected person-time in each trial arm; the bias and mean squared
error of b 2c as an estimator of b 2orig, where b 2c is the estimated variance parameter in the cth
projected dataset and e 2orig is the estimated variance parameter in the original dataset; and
the analogous bias and mean squared errors of  0,c and b 1,c, calculated as in Section 2.2 with
knot points at each week of follow-up.
3.2 Simulation Results
The proposed conditional power method successfully captured both general trends in study
conditional power across the simulation settings (Figure 3), as well as specific fluctuations in
evidence strength across the individual interim datasets (Figure 4; Web Figure S3). When
e 0, e 1,  2, and ⌘ were all set to their data-generating values, the mean conditional power
closely approximated the simulated study power for all baseline hazard, intervention e↵ect,
and dependence settings. This close correspondence confirms that—absent any estimation
error in either the event process or the correlation structure—the resulting conditional power
estimates reasonably capture (on average) the underlying study futility. When e 0, e 1,  2, and
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⌘ were instead estimated as in Sections 2.1 and 2.2—and as might be done in practice—the
mean conditional power continued to match the simulated trial power.
In addition to capturing aggregate trends in study futility, our proposed method pro-
duced individual conditional power estimates that correlated in a meaningful way with the
significance of the individual completed studies (Figure 4; Web Figure S3). Assuming a
futility threshold of 20% conditional power, 96.8% of all trials classified as futile at interim
had final p-values greater than ↵ = 0.05, while 93.0% of all trials classified as not futile
at interim had final p-values below ↵ = 0.05; the final correct classification rate over all
126,000 simulated trials was 94.1%. Although the accuracy rate dipped as low as 71.3% in the
independent data setting with low incidence and small intervention e↵ect, these classification
errors were attributable almost entirely to continuing studies that ultimately proved futile.
This elevated type II error rate is a reflection of the modest inflation of the mean conditional
power estimates relative to the study power observed in those simulation settings with near-
null intervention e↵ects (Figure 3). This inflation is likely the result of a floor e↵ect: even
when data are representative of a null intervention e↵ect, the observed conditional hazard
functions b Xi(t) will inevitably di↵er from one another slightly, and the resulting conditional
power estimates will reflect this spurious e↵ect.
Across all simulation settings considered, the proposed complete-trial projection procedure
also reasonably captured the salient features of the original trial data, with the bias and mean
squared error of the estimated log-frailty variance and conditional hazards all near zero (Web
Figures S4–S5). That being said, the bias, when present, tended to be slightly but persistently
negative: the projected complete-trial datasets had, on average, fewer events in each trial
arm than did the original complete-trial datasets, resulting in smaller within-arm incidences
and lower correlation (Web Tables S2–S3). This discrepancy diminished to near zero when
individuals were monitored for the event of interest on a bimonthly (as opposed to annual)
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basis (Web Table S5; Web Figure S6). This suggests that the bias was not the result of our
projection framework per se, but rather of imprecisions in the estimation of bS(t|Xi) due to
the limited information available at interim under the annual inspection schedule.
[Figure 3 about here.]
[Figure 4 about here.]
3.3 Sensitivity to the Study Design and Misspecification of the Frailty Distribution
Our proposed method produced reasonable conditional power estimates across several modifi-
cations to the CRT study design, including variations in the number and size of randomized
clusters (Web Table S4) and the frequency of the event inspections (Web Table S5; Web
Figure S6). Its performance was also robust to misspecification of the frailty distribution:
when the true frailties were gamma-distributed, the conditional power estimates derived
under the misspecified lognormal model were nearly identical to those under the correctly-
specified gamma model (Web Table S6).
4. The Botswana Combination Prevention Project
The Botswana Combination Prevention Project (BCPP) was a pair-matched CRT designed
to evaluate the impact of combination HIV prevention strategies on the population-level
three-year cumulative incidence of HIV (Gaolathe et al., 2016; Makhema et al., 2019).
Thirty communities in Botswana were pair-matched on the basis of size, pre-existing health
services, population age structure and geographic location, with one community in each pair
randomized to receive combination HIV prevention and the other to receive an enhanced
standard-of-care. An incidence cohort of HIV-negative individuals identified from a 20%
random sample from each community was tested for seroconversion at each of three annual
visits; an interim analysis was planned following the completion of all one-year visits.
At the beginning of the study in 2013, the combination prevention package included
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scaled-up HIV testing and counseling services, linkage-to-care support, enhanced mother-
to-child transmission prevention e↵orts, male circumcision campaigns, and extension of
antiretroviral therapy to those infected individuals with high viral load levels. The enhanced
standard-of-care included higher testing coverage (due to the annual testing of the incidence
cohort) and improved technical support for data management, but otherwise reflected the
contemporary standard practice. However, while the trial was ongoing the national HIV
treatment guidelines changed: the Botswana Ministry of Health recommended in 2016 that
all HIV-positive patients, regardless of CD4 count or viral load levels, initiate antiretroviral
therapy (Gaolathe et al., 2016). This change made the care administered to the control
communities more similar to that in the intervention communities, raising concerns that the
anticipated intervention e↵ect might be reduced and that the trial might be futile as a result.
Actual interim data from the BCPP remain confidential. As such, we used our proposed
method to conduct a futility assessment on a simulated interim dataset, generated by apply-
ing an agent-based epidemic model to a dynamic network of simulated sexual partnerships
(Wang et al., 2014). Both the sexual network and epidemic models were developed to project
the intervention e↵ect during the design phase of the BCPP, and the inputs to these models
were calibrated to resemble the actual study conditions (see Web Appendix E for details).
4.1 Futility Assessment Using the Network-Generated Data
The simulated BCPP trial followed an incidence cohort of 10,465 individuals across the 30
study communities: 5,225 of these individuals belonged to combination prevention communi-
ties, and 5,240 to enhanced standard-of-care communities. By the time of the interim analysis,
35 individuals in the combination prevention clusters and 50 individuals in the enhanced
standard-of-care clusters had seroconverted, corresponding to cluster-conditional incidence
rates of 0.0045 and 0.0064 events per person-year, respectively (estimated conditional hazard
ratio: 0.699). Assuming no change to these trends, the conditional power of the simulated
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BCPP was estimated to be 0.648. However, if the observed intervention e↵ect were to dimin-
ish by 10% over the remainder of the trial in response to the new Ministry of Health treatment
guidelines (reducing the hazard ratio from 0.699 to 0.769), the estimated conditional power
would drop to 0.478. Reductions in the underlying baseline hazard of seroconversion, as
might result from the mid-trial adoption of universal antiretroviral therapy initiation, also
led to a modest drop in the estimated conditional power (Table 1). For a full summary of
the estimated conditional power results, as well as information regarding the projected total
person-time of follow-up and number of HIV seroconversions at study conclusion across the
simulated complete-trial datasets, see Table 1. The full analysis was executed in R on a single
core of the Harvard Medical School O2 cluster and took approximately 3 hours to complete,
for an average time of 18 minutes per conditional power estimate.
[Table 1 about here.]
5. Discussion
We have proposed a flexible framework for calculating the conditional power of CRTs with
interval-censored endpoints. Our approach permits any assumed form for the conditional
hazard functions over the remainder of the study, and may be used with any final hypothesis
test of interest. This second feature presents a notable advantage over standard conditional
power formulae, which are typically specific to a given test statistic or class of test statistics.
Extensive simulation studies demonstrated that the proposed method produces reasonable
conditional power estimates across an array of data-generating models and a wide range of
study design parameters, and that it is robust to misspecification of the frailty distribution.
We observed mild inflation in the conditional power estimates in those settings with
low study power, most likely due to a floor e↵ect on the estimation of the intervention
e↵ect. However, the futility bound for clinical trials with conditional-power-based interim
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monitoring is often set between 10% and 30% (Zhang et al., 2017), with recent examples
including the oncology trial LUME-Lung 2, for which the futility threshold was set at
20% (Lesa↵re et al., 2017), and a psychiatric trial of maintenance treatment of bipolar I
disorder, for which the futility threshold was set at 30% (Mahableshwarkar et al., 2017).
Under these more conservative futility thresholds, our conditional power procedure remains
able to accurately discriminate between futile and non-futile trials at interim, even in the
presence of this mild conditional power inflation.
In order to estimate the cluster-conditional survival functions S(t|Xi; ⌘i), we adopted the
lognormal shared frailty model given in (1). Few computational methods permit stable fitting
of (1) to large clusters of interval-censored observations, and semiparametric estimation of
this model with correlated interval-censored data remains an open area of research. As such,
we used mid-point imputation to transform the interval-censored observations into right-
censored observations, from which we then estimated the log-frailty variance and individual
frailty terms. However, mid-point imputation has been shown to produce biased coe cient
estimates in (1), with the magnitude of the bias increasing with the width of the censoring
intervals. For this reason, we exploited the relationship between the marginal and conditional
survival functions to obtain a semiparametric estimator for S(t|Xi), rather than relying on a
mid-point imputed estimate. Further work is needed to develop stable procedures for fitting
frailty models directly to correlated interval-censored observations.
The main focus of this article has been on proposing a method for calculating point
estimates of the conditional power. Clinical decision-making would be further aided by
having some tool to characterize uncertainty in these estimates. One natural choice for
estimating this variability is the bootstrap 95% confidence interval. However, there are sev-
eral complications that arise when performing bootstrap resampling on correlated, interval-
censored observations, particularly when the outcome of interest is both rare and interval-
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censored. CRTs typically randomize only a small number of communities, so that bootstrap
resampling at the cluster level is unlikely to provide a reasonable approximation to the
sampling distribution. Resampling at the individual level conditional on cluster membership
is more amenable to a small M setting, but may produce clusters in which no event has
occurred when the outcome of interest is rare; this in turn limits the types of test statistics
that can be computed on the bootstrapped interim data. In light of these challenges, we
instead recommend conducting sensitivity analyses to assess the conditional power across
a range of projections that are compatible with the observed data; these analyses should
provide the additional context and uncertainty quantification needed for clinicians to make
appropriate and informed trial termination decisions at the futility boundary.
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Appendix A: Derivation of Equation (2)
Let S˙(t|Xi; ⌘i = 0) and S¨(t|Xi; ⌘i = 0) be the first and second partial derivatives of S(t|Xi; ⌘i)
with respect to ⌘i, evaluated at ⌘i = 0. Taking the second-order Taylor approximation of
S(t|Xi; ⌘i) about ⌘i = 0, we have
S(t|Xi; ⌘i) ⇡ S(t|Xi; ⌘i = 0) + S˙(t|Xi; ⌘i = 0)(⌘i   0) + 1
2
S¨(t|Xi; ⌘i = 0)(⌘2i   0)
= S(t|Xi)  ⌘i⇤(t|Xi)S(t|Xi) + ⌘
2
i
2
⇤(t|Xi)S(t|Xi){⇤(t|Xi)  1},
so that marginalizing over the frailty distribution yields
S(t|Xi) ⇡
Z 1
 1

S(t|Xi)  ⌘i⇤(t|Xi)S(t|Xi) + ⌘
2
i
2
⇤(t|Xi)S(t|Xi){⇤(t|Xi)  1}
 
 (⌘i)d⌘i
= S(t|Xi)

1 +
 2
2
⇤(t|Xi){⇤(t|Xi)  1}
 
,
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where  (⌘i) denotes the N(0,  2) density function.
Appendix B: Justification of Truncated Inverse Probability Integral Transform
To sample observations from the survival function in (3), subject to the restriction that eTij
must be larger than the right-censoring time Lij, we define the generalized inverse functioneS 1i (!|Xi; b⌘i) = inf{t|eSi(t|Xi; b⌘i) 6 !}. Then the truncated inverse probability integral
transform procedure draws U ⇠ Uniform 0, eSi(Lij|Xi; b⌘i)  and sets eTij := eS 1i (U |Xi; b⌘i).
Claim 1: The resulting eTij constitutes a random sample from the target conditional
distribution, eSi(t|Tij > Lij, Xi; b⌘i).
Proof. Consider the probability space (⌦,B, P ), where ⌦ =  0, eSi(Lij|Xi; b⌘i) , B is the
Borel  -algebra on ⌦, and P (·) = µ(·)/µ(⌦) with µ the Lebesgue measure. Define A! =
{! : eS 1i (!|Xi; b⌘i) > t} and B! = {! : ! 6 eSi(t|Xi; b⌘i)} for t 2 (Lij,1) and ! 2 
0, eSi(Lij|Xi; b⌘i) . Note that the desired result follows immediately if we are able to show
that P (A!) = P (B!), where P (B!) = eSi(t|Xi; b⌘i)/eSi(Lij|Xi; b⌘i) = eSi(t|Tij > Lij, Xi; b⌘i).
[)] Consider !⇤ 2 A!. Then eS 1i (!⇤|Xi; b⌘i) > t, so that t 62 {t : eSi(t|Xi; b⌘i) 6 !⇤}. So it
follows that eSi(t|Xi; b⌘i) > !⇤, which further implies that !⇤ 2 B! and A! ⇢ B!.
[(] Define B0! = {! : ! < eSi(t|Xi; b⌘i)} and consider !⇤ 2 B0!. By the right continuity ofeSi(t|Xi; b⌘i), there exists  !⇤ > 0 so that eSi(t|Xi; b⌘i)  eSi(t+ !⇤ |Xi; b⌘i) < eSi(t|Xi; b⌘i) !⇤ =)eSi(t+ !⇤ |Xi; b⌘i) > !⇤. Then t+ !⇤ 62 {t : eSi(t|Xi; b⌘i) 6 !⇤} and eS 1i (!⇤|Xi; b⌘i) > t+ !⇤ > t.
So !⇤ 2 A! and B0! ⇢ A!.
Note that P (B!) = P (B
0
!), and that B
0
! ⇢ A! ⇢ B! =) P (B0!) 6 P (A!) 6 P (B!). So
P (A!) = P (B!), as desired.
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Interim Data
Estimated Frailty
Frailty Variance
Characterization
of Event Process Censoring
Estimate the
cluster-specific
survival curves
Project the
survival curves
through the
end of the trial
Generate
correlated,
interval-censored
survival data
Obtain a p-
value for the
treatment e ect
Repeat to calculate conditional power
1
Figure 1. An overview of the proposed conditional power calculation approach. The shaded
boxes indicate the analysis pipeline, while the clear boxes indicate inputs to the pipeline that
may either be user-specified or informed by the observed interim data.
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1
Figure 2. Sample complete-trial generation process under monotone missingness for four
members of cluster i, with the observed data rendered in black and the projected data
rendered in blue. The final interval-censored observations are given on the right.
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Figure 3. Power and conditional power results as a function of the true, data-generating
baseline hazard, intervention e↵ect, and log-frailty variance in the generated interim data.
Each data point represents the mean estimated power (conditional power) across 1000
simulation runs.
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Web Appendix A. Alternate Frailty Specifications
Suppose that we conduct a cluster-randomized trial ofM communities (indexed i = 1, . . . ,M)
in which the outcome of interest is an interval-censored time-to-event with cluster-specific
hazard function
 (t|Xi; ⌘i) =  (t|Xi) exp(⌘i).
While the exposition in the main text assumed ⌘i ⇠ N(0,  2), the proposed method may be
generalized to any assumed frailty distribution f(exp(⌘); ✓) provided that one can (i) estimate
✓ and (⌘1, . . . , ⌘M)T and (ii) derive either an exact or approximate relationship between the
conditional survival function, S(t|Xi) = S(t|Xi; ⌘i = 0), and the induced marginal survival
distribution, S(t|Xi), in terms of these parameters. Two common alternative choices for the
frailty distribution are exp(⌘i) ⇠ Gamma(✓, ✓) and exp(⌘i) ⇠ Positive-Stable(↵).
A.1 Gamma Frailty Distribution
Define $i := exp(⌘i), and suppose $i ⇠ Gamma(✓, ✓) with E($i) = 1 and V ar($i) = ✓ 1.
Then
S(t|Xi) =
Z 1
 1
S(t|Xi;$i)f($i; ✓)d$i
=
Z 1
 1
exp { ⇤(t|Xi)$i} ✓
✓
 (✓)
$✓ 1i e
 ✓$id$i
=
✓✓
 (✓)
Z 1
 1
exp [  {⇤(t|Xi) + ✓}$i]$✓ 1i d$i
=
⇢
✓
⇤(t|Xi) + ✓
 ✓
,
where ⇤(t|Xi) =
R t
0  (u|Xi)du is the cumulative conditional hazard function. Note that ✓
may be estimated by direct maximization of the marginal likelihood and ($1, . . . ,$M)T by
empirical Bayes (see, for example, Klein (1992) and Nielsen et al. (1992)), and that the
conditional survival function may be written as an explicit function of S(t|Xi) and ✓:
S(t|Xi) = exp
⇥ ✓  S(t|Xi) 1/✓   1 ⇤ .
3Then our proposed conditional power procedure proceeds exactly as described in the main
paper, with bS(t|Xi; b$i) = bS(t|Xi)b$i .
A.2 Positive Stable Frailty Distribution
Alternatively, suppose $i ⇠ Positive-Stable(↵) for ↵ 2 (0, 1], where the positive stable
distributional family is characterized by its Laplace transform
E{exp( c$i)} = exp( c↵). (A.1)
In light of (A.1), we may immediately write down an exact relationship between the marginal
and cluster-conditional survival functions, with
S(t|Xi) = E [exp { ⇤(t|Xi)$i}] = exp { ⇤(t|Xi)↵} = exp [  {  logS(t|Xi)}↵] .
The frailty parameters ↵ and ($1, . . . ,$M)T may once again be estimated by direct max-
imization of the marginal likelihood and by empirical Bayes, and the conditional survival
function may be estimated using the inverse relationship
S(t|Xi) = exp
h
    logS(t|Xi) 1/↵i .
Then the remainder of the conditional power procedure proceeds as before, with bS(t|Xi; b$i) =bS(t|Xi)b$i .
Web Appendix B. Marginal & Cluster-Conditional Survival Functions
In this section we discuss the relationship between the conditional and induced marginal
survival functions under gamma, positive stable, and lognormal frailty models:
$i ⇠ Gamma(✓, ✓) S(t|Xi) =
⇢
✓
⇤(t|Xi) + ✓
 ✓
(A.2)
$i ⇠ Positive-Stable(↵) S(t|Xi) = exp { ⇤(t|Xi)↵} (A.3)
⌘i ⇠ N(0,  2) S(t|Xi) ⇡ S(t|Xi)

1 +
 2
2
⇤(t|Xi){⇤(t|Xi)  1}
 
(A.4)
We also comment on the performance of the approximation in (A.4), and demonstrate
visually that the approximation error is small in settings with mild to moderate dependence.
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B.1 Curve Comparison
(A.2) Under the gamma frailty model, an application of Jensen’s inequality demonstrates
that the marginal survival function always lies above the conditional curve:
S(t|Xi) = E{S(t|Xi)$i} > S(t|Xi)E($i) = S(t|Xi),
with the extent of the discrepancy vanishing as V ar($i) = ✓ 1 ! 0 or ⇤(t|Xi)! 0.
(A.3) In the positive stable model, we instead observe that for ↵ 2 (0, 1), the marginal
survival function lies below the conditional survival function until ⇤(t|Xi) = 1, at which
point the two curves cross:
S(t|Xi) > S(t|Xi) () exp { ⇤(t|Xi)↵} > exp { ⇤(t|Xi)}
() ⇤(t|Xi)↵ 6 ⇤(t|Xi)
() ⇤(t|Xi) > 1.
When ↵ = 1, the positive stable distribution reduces to a point mass at one, such that all
survival times are independent of one another and the marginal and conditional survival
functions trivially coincide.
The positive stable distribution also has the notable feature that—assuming the event times
follow a Weibull distribution with common shape parameter —it preserves proportionality
of the hazards under marginalization (Hougaard, 1986). In particular, if the hazard within
cluster i is given by
 (t|Xi;$i) =   1 (t/ ) 1 exp( Xi)$i,
then the marginal distribution
S(t|Xi) = E
⇥
exp
   (t/ ) exp( Xi)$i ⇤ = exp   (t )↵ exp(↵ Xi) 
is also Weibull, but with both the shape parameter and the log hazard ratio scaled by ↵; the
latter implies an attenuation of the cluster-conditional e↵ect on the marginal scale. Under
Weibull failure times the positive stable parameter also has an intuitive interpretation in
5terms of the within-cluster correlation: corr(log Tij, log Tij0) = 1  ↵2 (Hougaard, 1986).
(A.4) In the lognormal frailty model, we see that the marginal survival function will closely
approximate the conditional survival function when the contribution of the second term in
(A.4) is negligible. This occurs whenever the observations in the study are approximately
uncorrelated: either as the result of a small frailty variance, a low study incidence, or minimal
observed follow-up time. Furthermore, we see that, as in the positive stable model, S(t|Xi)
will generally lie below S(t|Xi) whenever ⇤(t|Xi) < 1:
S(t|Xi)  S(t|Xi) ⇡  
2
2
⇤(t|Xi){⇤(t|Xi)  1}
=) sign S(t|Xi)  S(t|Xi) = sign ⇤(t|Xi)  1 .
Thus in our low incidence simulation studies, where  (t|Xi = 0) was set to 0.001, S(t|Xi = 0)
underestimated S(t|Xi = 0) at all time-points; in our high incidence simulation studies, where
 (t|Xi = 0) was set to 0.01, S(t|Xi = 0) underestimated S(t|Xi = 0) until t = 100 weeks.
B.2 Approximation Performance
As discussed in Section 2.1 of the main text, the approximation in (A.4) permits estimation
of the conditional survival function S(t|Xi) as the root of
g(y) = y
⇢
1 +
b 2
2
log y(log y + 1)
 
  bS(t|Xi), (B.1)
where bS(t|Xi) is the nonparametric maximum likelihood estimator of S(t|Xi) and b 2 is an
estimator of the log-frailty variance. Here we consider the extent of the resulting approxima-
tion error when both S(t|Xi) and  2 are known, i.e., when the error is attributable solely to
the use of a second-order Taylor approximation; we also compare the performance of bS(t|Xi)
to the performance of S(t|Xi) as (potentially na¨ive) estimators of S(t|Xi). The settings used
for this comparison are given in Web Table S1.
[Table 1 about here.]
As anticipated, S(t|Xi) underestimated S(t|Xi) when the cumulative incidence was small,
6 Biometrics, Web Appendix
with the extent of this discrepancy increasing in direct correspondence with the log-frailty
variance (Web Figures S1 and S2). The Taylor-approximated bS(t|Xi) closely matched the
true S(t|Xi) in all low incidence settings considered, and diverged substantially from S(t|Xi)
only when both the extent of the clustering e↵ect was extreme and the cumulative incidence
was large. Note, however, that the performance documented in Web Figures S1 and S2 is an
optimistic assessment of bS(t|Xi) as an estimator of S(t|Xi) in practice: estimation of both
S(t|Xi) and  2 will necessarily introduce additional error into the approximation. While we
anticipate that bS(t|Xi) will still provide a better representation of the underlying conditional
survival function than S(t|Xi), the relative improvement may be small in settings with low
dependence.
[Figure 1 about here.]
[Figure 2 about here.]
Web Appendix C. Additional Simulation Results
In this section we provide additional results regarding the ability of our conditional power
procedure to:
(C.1) respond to specific fluctuations in evidence strength across the individual study
datasets; and
(C.2) generate complete-trial datasets that reasonably capture—in aggregate—the salient
features of the observed trial data, had the observed trial run to completion.
To briefly summarize, our simulation study first generated 1000 complete-trial datasets for
each unique combination of baseline hazard  0, intervention e↵ect  , and log-frailty variance
 2. We then truncated these datasets following two years of follow-up to create the interim
analysis datasets to which our proposed conditional power procedure was applied. Greater
7detail regarding the simulation study design and simulation parameters is available in Section
3.1 of the main paper.
C.1 Study-Specific Concordance
Select mosaic and conditional power distribution plots demonstrating our proposed method’s
study-specific classification performance when  0 = 0.001 and k = 0.25 are given in Web Fig-
ure S3. The interim futility classification was based on a futility threshold of 20% conditional
power, and the final study significance was based on a significance level of ↵ = 0.05.
[Figure 3 about here.]
C.2 Generation of Complete-Trial Datasets
Web Figures S4 and S5 presents bias and mean squared error results for the estimated
conditional hazards and log-frailty variance in the projected complete-trial datasets, taken
as estimators of those same quantities in the original complete-trial data. Web Tables S2 and
S3 similarly compare the average number of recorded events, the average number of person-
weeks under observation, and the average incidence rates within each arm of the original and
projected compete-trial data.
Our projected datasets mildly but persistently underreported the number of events in each
trial arm, with this underestimation becoming more prominent in the high incidence setting
(Web Figure S5). It is worth noting, however, that the underestimation was largely invariant
to the size of the log-frailty variance, and that it persisted even when the data-generating
values of  0,  1,  2, and ⌘ were used to create the projected datasets. In Web Appendix D,
we also see that the discrepancy diminished to near zero when individuals were monitored
on a more frequent bimonthly inspection schedule. This suggests that the bias noted in Web
Figures S4–S5 and the underreporting noted in Web Tables S2–S3 are consequences of the
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limited information available at interim under an annual inspection schedule, and not an
inherent feature of the method itself.
[Figure 4 about here.]
[Figure 5 about here.]
[Table 2 about here.]
[Table 3 about here.]
Web Appendix D. Sensitivity Analyses
We also conducted a series of focused simulation studies to explore the robustness of our
proposed conditional power method to the size and number of randomized clusters, to the
width of the censoring interval, and to possible misspecification of the frailty distribution. The
simulation design for the sensitivity analyses closely matched that of the primary simulation
study (detailed in Section 3.1 of the main paper) except where noted, though we restricted
our focus to the low incidence ( 0 = 0.001) and low dependence (k = 0.25) setting. We
also took   2 {0, 0.2, 0.4}, selected to produce trials with approximately 5%, 41.2%, and
92.6% empirical power, respectively. The results of the analyses are presented in Sections
D.1–D.3 below.
D.1 Size and Number of Clusters
While many pragmatic CRTs randomize a small number of large clusters—the sort of study
design considered in our primary simulation study—studies targeted at a community or
household level may randomize a larger number of small clusters (e.g., Guiteras et al. (2015)).
In acknowledgment of these alternative CRT designs, we conducted sensitivity analyses under
two di↵erent large M scenarios: one in which M = 90 and ni ⇠ Uniform(50, 150), and the
second in which M = 300 and ni ⇠ Uniform(10, 50). In both settings, the expected total
9sample size,
P
i ni = 9000, matched that from the primary simulation study. Our results
suggest our conditional power projection procedure is robust to the size and number of
randomized clusters: it produces reasonable conditional power estimates (Web Table S4)
even when M ⇡ ni (scenario one) or M   ni (scenario two). Complete-trial data generation
and study-specific concordance results are omitted, but were broadly similar to those in Web
Appendix C and the main text.
[Table 4 about here.]
D.2 Width of the Censoring Interval
In trials with interval-censored outcomes, the event monitoring schedule that participants
follow has potentially large implications for the amount of information available at the
interim analysis. The less frequent the inspections, the wider the censoring intervals and
the more uncertain the estimates of the within-cluster dependence, the community-specific
frailty terms, and the observed trends in incidence. This, in turn, has implications for the
quality of the conditional power projections.
Both the BCPP and our primary simulation study operated on one end of the extreme: the
inspections followed an annual schedule, and study participants had at most two inspections
prior to the interim analysis. To determine the extent to which this monitoring schedule may
have contributed to mild under-projection of the number of events (Web Figure S4–S5; Web
Tables S2–S3) and mild inflation in the conditional power estimates (Figure 3), we conducted
a second sensitivity analysis assuming K = 26 bimonthly inspections planned at ⌧k = 8k
weeks, k = 1, . . . , 26. As in the primary simulation study, individual participant monitoring
times then followed a Uniform(⌧k 4, ⌧k+4) distribution about these planned visits. Finally,
for this sensitivity analysis only, we considered both low ( 0 = 0.001) and high ( 0 = 0.01)
incidence settings, as the downward bias noted in the projected number of events appeared
to increase with the underlying event rate.
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Conditional power estimates under both the low and high incidence settings are given in
Web Table S5, while the ability of the conditional power procedure to recapitulate features
of the original completed trials when  0 = 0.01 is given in Web Figure S6 (results when
 0 = 0.001 were similar to those in Web Appendix C). Crucially, we see that the persistent
underestimation of the conditional incidence rates noted in the main simulation study disap-
peared with more frequent bimonthly inspections, where the bimonthly inspections provided
correspondingly more information at interim with which to estimate the conditional survival
curves.
[Table 5 about here.]
[Figure 6 about here.]
D.3 Specification of the Frailty Distribution
To examine the robustness of our proposed conditional power method to misspecification of
the frailty distribution, we conducted a final sensitivity analysis in which the data-generating
model was
 (t|Xi;$i) = 0.001 exp( Xi)$i,
with $i ⇠ Gamma(1/0.06, 1/0.06). We calculated the conditional power under the following
three scenarios:
(1) The frailty distribution was misspecified as lognormal, and equation (B.1) was used to
estimate the conditional survival functions, bS(t|Xi); the projected/estimated e 0, e 1, b 2,
and b⌘ were then used to extend these functions through the remainder of the trial.
(2) The frailty distribution was correctly specified, and equation (A.2) was used to estimate
the conditional survival functions, bS(t|Xi); the projected/estimated e 0, e 1, b✓, and c$
were then used to extend these functions through the remainder of the trial.
(3) The frailty distribution was correctly specified, and equation (A.2) was used to estimate
11
the conditional survival functions, bS(t|Xi); the data-generating  0,  1, ✓, and $ were
then used to extend these functions through the remainder of the trial.
As shown in Web Table S6, misspecification of the frailty distribution had a negligible impact
on the final conditional power estimates: the mean conditional power under scenarios (1)
and (2) di↵ered by at most 0.005 points, and the two models produced identical interim
futility classifications for 2,979 of the 3,000 generated interim datasets. Complete-trial data
generation and study-specific concordance results are omitted, but demonstrated similar
trends to those observed in Web Appendix C.
[Table 6 about here.]
Web Appendix E. BCPP Data Generation
We used the same agent-based epidemic model as in Wang et al. (2014), developed during
the design stage of the BCPP to project the study-specific incidence of HIV, to generate an
interim analysis dataset modeled after the trial. The simulation approach consisted of first
generating sexual networks representative of the trial communities before then propagating
disease transmission on these networks.
The simulated study-wide sexual network was comprised of 15 independent sub-networks,
each corresponding to a matched pair of intervention and standard-of-care communities;
these sub-networks captured all heterosexual partnerships between and within the matched
communities. For each sub-network, the distribution of number of partnerships per individ-
ual was estimated from comprehensive sexual network data from Likoma Island, Malawi
(Helleringer and Kohler, 2007), and the extent of sexual mixing between the two matched
communities was informed by a pilot study in Mochudi, Botswana (Wang et al., 2014). We
used the method of Goyal et al. (2013) to generate sexual networks compatible with these
two distributional constraints. The duration of each generated partnership was then drawn
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from a survival distribution estimated from data collected in the Mochudi study, and the
start date of each generated partnership was drawn uniformly at random over the study
period.
We then propagated HIV on these networks using an agent-based epidemic model, in which
both individual and community characteristics informed the spread of disease. At the start of
the simulation, each individual in the collection of networks was assigned an infection status
at random based on current estimates of HIV prevalence in Botswana, reported in Gaolathe
et al. (2016) as 29%. Infected individuals were then assigned a viral load category and CD4
count, and characteristics such as transmission probabilities, individual risk-increasing and
risk-reducing behaviors, and projected intervention uptake and e↵ects were used to determine
HIV spread. A complete listing of the input parameters is given in Web Table S7.
We assumed that a random sample of 20% of each community was selected to receive
yearly HIV tests, and that the remainder of the community was tested at a background rate
corresponding to the community’s intervention or standard-of-care status. The simulation
ran for a total of three years; we truncated the data at 82 weeks for the purposes of creating
an interim analysis dataset.
[Table 7 about here.]
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Figure S1. Comparison of the true conditional survival function, S(t|Xi), the induced
marginal function, S(t|Xi), and the Taylor-approximated conditional function, bS(t|Xi),
under exponential-distributed failure times and low (top row) and high (bottom row)
incidence settings. The distance metrics d(S, S) := kS   Sk1 and d(S, bS) := kS   bSk1
were defined over the set [0, 208].
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Figure S2. Comparison of the true conditional survival function, S(t|Xi), the induced
marginal function, S(t|Xi), and the Taylor-approximated conditional function, bS(t|Xi),
under Weibull-distributed failure times and low (top row) and high (bottom row) incidence
settings. The distance metrics d(S, S) := kS   Sk1 and d(S, bS) := kS   bSk1 were defined
over the set [0, 208].
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Figure S3. Distribution of interim conditional power estimates stratified by significance at
the ↵ = 0.05 level of the completed trial (top row), as well as the corresponding classification
performance assuming a futility threshold of 20% conditional power (bottom row), for select
low incidence ( 0 = 0.001) and low dependence (k = 0.25) simulation settings. All plots are
summarized over 1000 simulated interim datasets.
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Figure S4. Bias and squared error of the estimated conditional hazards (left, center)
and log-frailty variance (right) in the projected complete-trial datasets as estimators of
the analogous quantities in the original completed trials. The original data were gener-
ated with  0 = 0.001, and selected results are presented for   = ( 0.2, 0.0, 0.2) and
k = (0.00, 0.25, 0.50).
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Figure S5. Bias and squared error of the estimated conditional hazards (left, center)
and log-frailty variance (right) in the projected complete-trial datasets as estimators of the
analogous quantities in the original completed trials. The original data were generated with
 0 = 0.01, and selected results are presented for   = ( 0.2, 0.0, 0.2) and k = (0.00, 0.25, 0.50).
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Figure S6. Sensitivity of features of the projected complete-trial datasets (considered as
estimators of the analogous quantities in the original completed trials) to the width of the
censoring interval under high incidence ( 0 = 0.01) and low dependence (k = 0.25).
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Table S1
Attributes of the cluster-conditional model, S(t|Xi = 0), under lognormal frailties and either exponential or Weibull
hazards. The Weibull distribution was parametrized so that E(Ti) =   (1 + 1/), and the parameters chosen so that
the survival at 208 weeks would be the same under both distributions.
Survival Distribution
Exponential Weibull
Low Incidence:   = 0.001  = 0.5,   = 4807.692
High Incidence:   = 0.01  = 2.0,   = 144.2221
Frailty Distribution
Variance:  2 = 0.22, 0.45, 0.69 (k = 0.50, 0.75, 1.00)
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Table S4
Sensitivity of power and conditional power results to the number and size of randomized clusters under low incidence
( 0 = 0.001) and low dependence (k = 0.25). Results are summarized via the mean and empirical standard error
over 1000 simulation runs.
Power
Conditional Power
Power
Conditional Power
(e 0, e 1, b 2, b⌘) ( 0,  1,  2, ⌘) (e 0, e 1, b 2, b⌘) ( 0,  1,  2, ⌘)
Scenario One (M ⇡ ni) Scenario Two (M   ni)
  = 0.0 0.050 0.154 (0.269) 0.055 (0.132) 0.050 0.150 (0.247) 0.052 (0.122)
  =  0.2 0.689 0.669 (0.375) 0.692 (0.290) 0.811 0.734 (0.342) 0.796 (0.265)
  =  0.4 0.997 0.987 (0.068) 0.998 (0.012) 1.000 0.996 (0.035) 1.000 (0.002)
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Table S5
Sensitivity of power and conditional power results to the width of the censoring interval under low dependence
(k = 0.25). Results are summarized via the mean and empirical standard error over 1000 simulation runs.
Power
Conditional Power
Power
Conditional Power
(e 0, e 1, b 2, b⌘) ( 0,  1,  2, ⌘) (e 0, e 1, b 2, b⌘) ( 0,  1,  2, ⌘)
 0 = 0.001  0 = 0.01
  = 0.0 0.050 0.112 (0.250) 0.059 (0.182) 0.050 0.053 (0.206) 0.049 (0.196)
  =  0.2 0.416 0.447 (0.417) 0.410 (0.398) 0.508 0.541 (0.460) 0.542 (0.460)
  =  0.4 0.929 0.916 (0.223) 0.936 (0.181) 0.975 0.975 (0.137) 0.976 (0.136)
25
Table S6
Sensitivity of power and conditional power results to misspecification of the frailty distribution under low incidence
( 0 = 0.001) and low dependence (✓ = 1/0.06). Results are summarized via the mean and empirical standard error
over 1000 simulation runs.
Power
Conditional Power
(e 0, e 1, b 2, b⌘) (e 0,  1, b✓, f$) ( 0,  1, ✓, $)
  = 0.0 0.050 0.101 (0.234) 0.104 (0.235) 0.053 (0.161)
  =  0.2 0.412 0.454 (0.422) 0.459 (0.423) 0.411 (0.402)
  =  0.4 0.927 0.894 (0.249) 0.895 (0.248) 0.917 (0.213)
26 Biometrics, Web Appendix
Table S7
Input parameters used to generate data representative of the Botswana Combination Prevention Project.
Parameter Value
Network Generation Parameters
Rate of spatial mixing between communities 0.210
Variance of spatial mixing between communities 0.00651
Community size (individuals) 2,500
Proportion of community in incidence cohort 0.200
Disease Characteristics
HIV prevalence at baseline 0.290
Prevalence of each viral load category
Viral load: (0, 400] copies/mL 0.139
Viral load: (400, 3500] copies/mL 0.174
Viral load: (3500, 10000] copies/mL 0.158
Viral load: (10000, 500000] copies/mL 0.268
Viral load: > 50000 copies/mL 0.261
Probability of transmission per 100 person-years
Viral load: (0, 400] copies/mL 0.000
Viral load: (400, 3500] copies/mL 0.045
Viral load: (3500, 10000] copies/mL 0.120
Viral load: (10000, 500000] copies/mL 0.140
Viral load: > 50000 copies/mL 0.230
Individual Attributes at Baseline
Percent of males who are circumcised 0.127
Percent of individuals who use condoms regularly 0.400
Reduction in acquisition risk from circumcision 0.600
Reduction in transmission risk from regular condom use 0.800
Percent of HIV+ individuals eligible for ART at baseline (CD4 < 350 cells/mm3) 0.887
Percent of individuals on ART among those eligible 0.400
Percent of individuals with high viral load (> 50000 copies/mL) that are ART naive 0.530
Intervention Components
Linkage-to-care rates in standard-of-care communities 0.800
Linkage-to-care rates in intervention communities 0.900
Male circumcision coverage
Standard-of-care communities Intervention communities
Year 1 0.314 0.464
Year 2 0.500 0.600
Year 3 0.600 0.680
HIV testing and counseling rates (among those not in the incidence cohort)
Standard-of-care communities Intervention communities
Year 1 0.243 0.790
Year 2 0.430 0.850
Year 3 0.470 0.900
